[Effect of suprainhibitory (supra-MIC) concentration of clindamycin on endotoxin release from Bacteroides fragilis]

A Rokosz1, F Meisel-Mikołajczyk

  • 1Zakład Mikrobiologii Lekarskiej AM w Warszawie.

Medycyna Doswiadczalna I Mikrobiologia
|June 24, 2000
PubMed

Insights

Clindamycin, at 100 times the minimum inhibitory concentration (MIC), inhibits *Bacteroides fragilis* growth. This high dose does not increase endotoxin release from the bacterial cells in vitro.

Area of Science:

  • Microbiology
  • Pharmacology
  • Immunology

Background:

  • *Bacteroides fragilis* is an opportunistic pathogen.
  • Endotoxins are critical virulence factors in Gram-negative bacteria.
  • Understanding antibiotic effects on endotoxin release is crucial for managing infections.

Purpose of the Study:

  • To investigate the impact of a high clindamycin concentration (100 x MIC) on *B. fragilis* growth.
  • To determine if this clindamycin dose induces augmented endotoxin release from *B. fragilis* cells.

Main Methods:

  • *B. fragilis* IPL E 323 strain cultured in BHI medium with or without clindamycin (12.5 mg/l).
  • Optical density measured to assess bacterial growth.
  • Supernatants analyzed for endotoxin using immunoelectroprecipitation (IEP) and dot-ELISA.

Main Results:

  • *B. fragilis* IPL E 323 spontaneously releases endotoxin into the culture medium.
  • Clindamycin at 100 x MIC significantly inhibited bacterial growth.
  • No augmented endotoxin release was observed from *B. fragilis* cells treated with high-dose clindamycin.

Conclusions:

  • A suprainhibitory dose of clindamycin effectively inhibits *B. fragilis* growth in vitro.
  • This specific high concentration of clindamycin does not lead to increased endotoxin release, suggesting a potentially favorable safety profile regarding endotoxemia during treatment.